Impact of the COVID-19 pandemic on adults with moderate-to-severe atopic dermatitis in the Dutch general population
Open Access
- 28 December 2021
- journal article
- letter
- Published by Elsevier in JAAD International
- Vol. 6, 86-93
Abstract
No abstract availableKeywords
Funding Information
- Pfizer BV
- China Scholarship Council (201806200089)
This publication has 5 references indexed in Scilit:
- Prevalence of adult atopic dermatitis in the general population, with a focus on moderate‐to‐severe disease: results from the Lifelines Cohort StudyJournal of the European Academy of Dermatology and Venereology, 2021
- SARS‐CoV‐2 infection in patients with atopic dermatitis: a cross‐sectional studyBritish Journal of Dermatology, 2021
- Lifelines COVID-19 cohort: investigating COVID-19 infection and its health and societal impacts in a Dutch population-based cohortBMJ Open, 2021
- Concerns related to the coronavirus disease 2019 pandemic in adult patients with atopic dermatitis and psoriasis treated with systemic immunomodulatory therapy: a Danish questionnaire surveyJournal of the European Academy of Dermatology and Venereology, 2020
- Cohort Profile: LifeLines, a three-generation cohort study and biobankInternational Journal of Epidemiology, 2014